89.30
price up icon0.31%   0.28
after-market アフターアワーズ: 89.32 0.02 +0.02%
loading
前日終値:
$89.02
開ける:
$88.55
24時間の取引高:
1.22M
Relative Volume:
0.73
時価総額:
$44.00B
収益:
$9.93B
当期純損益:
$1.12B
株価収益率:
39.69
EPS:
2.25
ネットキャッシュフロー:
$1.58B
1週間 パフォーマンス:
+1.98%
1か月 パフォーマンス:
+4.85%
6か月 パフォーマンス:
+7.01%
1年 パフォーマンス:
+0.57%
1日の値動き範囲:
Value
$88.55
$89.51
1週間の範囲:
Value
$86.94
$89.52
52週間の値動き範囲:
Value
$80.48
$101.10

Alcon Inc Stock (ALC) Company Profile

Name
名前
Alcon Inc
Name
セクター
Healthcare (1166)
Name
電話
-
Name
住所
-
Name
職員
25,599
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
ALC's Discussions on Twitter

ALC を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Instruments & Supplies icon
ALC
Alcon Inc
89.30 44.00B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
540.60 189.82B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
177.27 49.98B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
RMD
Resmed Inc
255.88 37.05B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
221.22 16.36B 2.90B 467.20M 306.90M 6.37

Alcon Inc Stock (ALC) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-20 ダウングレード Deutsche Bank Buy → Hold
2025-05-14 繰り返されました BTIG Research Buy
2025-03-28 繰り返されました Needham Buy
2025-03-25 アップグレード BofA Securities Neutral → Buy
2025-01-24 繰り返されました Needham Buy
2025-01-10 アップグレード Redburn Atlantic Neutral → Buy
2024-12-17 繰り返されました Needham Buy
2024-11-12 繰り返されました Needham Buy
2024-10-10 アップグレード Redburn Atlantic Sell → Neutral
2024-09-10 アップグレード RBC Capital Mkts Sector Perform → Outperform
2024-07-15 アップグレード Morgan Stanley Underweight → Equal-Weight
2024-05-15 アップグレード Oppenheimer Perform → Outperform
2024-04-10 開始されました Goldman Buy
2024-03-14 開始されました RBC Capital Mkts Sector Perform
2024-02-06 再開されました KeyBanc Capital Markets Overweight
2024-01-23 開始されました Bernstein Outperform
2023-12-18 ダウングレード Redburn Atlantic Neutral → Sell
2023-12-12 開始されました Stifel Buy
2023-12-04 ダウングレード Morgan Stanley Equal-Weight → Underweight
2023-08-17 アップグレード JP Morgan Neutral → Overweight
2023-05-30 再開されました Morgan Stanley Equal-Weight
2023-05-10 アップグレード Robert W. Baird Neutral → Outperform
2023-03-01 アップグレード Societe Generale Sell → Hold
2022-12-22 開始されました Mizuho Buy
2022-11-17 ダウングレード Societe Generale Hold → Sell
2022-08-11 ダウングレード Societe Generale Buy → Hold
2022-05-13 再開されました Credit Suisse Outperform
2022-05-12 アップグレード Stephens Equal-Weight → Overweight
2022-04-08 開始されました Needham Buy
2022-03-11 開始されました BofA Securities Buy
2022-01-18 ダウングレード Stephens Overweight → Equal-Weight
2022-01-07 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-10-01 開始されました Oppenheimer Perform
2021-07-14 開始されました Deutsche Bank Buy
2021-05-06 アップグレード Citigroup Sell → Neutral
2021-03-22 アップグレード BTIG Research Neutral → Buy
2020-11-12 ダウングレード Guggenheim Buy → Neutral
2020-07-06 ダウングレード Citigroup Neutral → Sell
2020-07-06 開始されました KeyBanc Capital Markets Sector Weight
2020-06-16 アップグレード Guggenheim Neutral → Buy
2020-04-08 ダウングレード Robert W. Baird Outperform → Neutral
2020-03-26 アップグレード Argus Hold → Buy
2020-03-24 アップグレード Societe Generale Sell → Hold
2020-03-13 アップグレード UBS Neutral → Buy
2020-03-05 開始されました Citigroup Neutral
2020-02-26 アップグレード Berenberg Hold → Buy
2020-01-08 開始されました Argus Hold
2019-10-29 開始されました Stephens Equal-Weight
2019-08-21 繰り返されました BofA/Merrill Neutral
2019-06-24 開始されました SVB Leerink Mkt Perform
2019-06-14 開始されました BTIG Research Neutral
2019-05-10 開始されました Robert W. Baird Outperform
2019-05-02 開始されました Credit Suisse Outperform
すべてを表示

Alcon Inc (ALC) 最新ニュース

pulisher
Jun 18, 2025

Alcon and Merit Medical: Creating Regulatory and Quality Business Value with AI - Veeva

Jun 18, 2025
pulisher
Jun 18, 2025

Should Weakness in Alcon Inc.'s (VTX:ALC) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - simplywall.st

Jun 18, 2025
pulisher
Jun 09, 2025

Alcon Gets First FDA Approval Since Novartis Spinoff - Orange County Business Journal

Jun 09, 2025
pulisher
Jun 09, 2025

Alcon’s Tryptyr Adds Growth, But Valuation Keeps Shares On 'Hold' (NYSE:ALC) - Seeking Alpha

Jun 09, 2025
pulisher
Jun 06, 2025

Alcon Stock Rated Buy by BTIG Following TRYPTYR Approval - MSN

Jun 06, 2025
pulisher
Jun 06, 2025

Phacoemulsification Devices Market Is Booming Worldwide - openPR.com

Jun 06, 2025
pulisher
Jun 05, 2025

Alcon: Achieving UDI Compliance with Veeva RIM - Veeva

Jun 05, 2025
pulisher
Jun 05, 2025

Alcon (ALC) Receives Increased Price Target from Citi | ALC Stoc - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Alcon (ALC) Receives Increased Price Target from Citi | ALC Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Citi more constructive on EU MedTech: Upgrades Demant; Alcon top pick - Investing.com Canada

Jun 05, 2025
pulisher
Jun 05, 2025

Alcon Inc. (ALC)’s TRYPTYR Wins FDA Nod for Dry Eye Disease - MSN

Jun 05, 2025
pulisher
Jun 03, 2025

BofA Securities lowers Alcon stock price target after Q1 results By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 03, 2025

BofA Securities lowers Alcon stock price target after Q1 results - Investing.com Australia

Jun 03, 2025
pulisher
Jun 02, 2025

Refractive Surgery Market Is Booming So Rapidly 2025-2032 - openPR.com

Jun 02, 2025
pulisher
Jun 01, 2025

Alcon up 4% as FDA approves Tryptyr drops for dry eye - MSN

Jun 01, 2025
pulisher
May 30, 2025

Citi maintains Buy on Alcon, price target CHF99 after FDA nod - Investing.com Nigeria

May 30, 2025
pulisher
May 30, 2025

Alcon gains FDA approval of Tryptyr in DED - The Pharma Letter

May 30, 2025
pulisher
May 30, 2025

BTIG maintains Alcon $99 target, upbeat on TRYPTYR launch By Investing.com - Investing.com Canada

May 30, 2025
pulisher
May 30, 2025

Citi maintains Buy on Alcon, price target CHF99 after FDA nod By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 29, 2025

FDA Approves Alcon’s Tryptyr for Dry Eye Disease - Managed Healthcare Executive

May 29, 2025
pulisher
May 29, 2025

Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019 - Benzinga

May 29, 2025
pulisher
May 29, 2025

Alcon Stock Rises Following the FDA Approval of TRYPTYR - MSN

May 29, 2025
pulisher
May 29, 2025

US FDA approves Alcon's new dry-eye drug - Reuters

May 29, 2025
pulisher
May 29, 2025

FDA approves Alcon’s Tryptyr (AR-15512) for signs and symptoms of dry eye disease - Ophthalmology Times

May 29, 2025
pulisher
May 29, 2025

Alcon receives FDA approval for Tryptyr to treat dry eye disease - World Pharmaceutical Frontiers

May 29, 2025
pulisher
May 29, 2025

FDA approves Alcon’s TRYPTYR for Dry Eye Disease treatment By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 29, 2025

BTIG maintains Alcon $99 target, upbeat on TRYPTYR launch - Investing.com

May 29, 2025
pulisher
May 29, 2025

Alcon’s Strategic Initiatives and Valuation Justify Buy Rating with $99 Price Target - TipRanks

May 29, 2025
pulisher
May 28, 2025

US FDA Approves Alcon's Dry Eye Disease Treatment - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

US FDA approves Alcon’s new dry-eye drug - The Mighty 790 KFGO

May 28, 2025
pulisher
May 28, 2025

Alcon (ALC) Gains FDA Approval for Innovative Dry Eye Treatment - GuruFocus

May 28, 2025
pulisher
May 28, 2025

US FDA approves Alcon's new dry-eye drug (May 28) - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic s - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Alcon (ALC) Gains FDA Nod for Innovative Dry Eye Treatment | ALC Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease | ALC Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

FDA approves Alcon’s TRYPTYR for Dry Eye Disease treatment - Investing.com

May 28, 2025
pulisher
May 28, 2025

Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Gordon Schanzlin New Vision Institute First in Region to Offer Groundbreaking Alcon Sitemap Technology for Personalized Vision Correction - GlobeNewswire Inc.

May 28, 2025
pulisher
May 28, 2025

BTIG maintains Alcon stock Buy rating, $99 target By Investing.com - Investing.com South Africa

May 28, 2025
pulisher
May 27, 2025

DOJ Requires Keysight to Shed Spirent Units Before $1.57 Billion Acquisition Proceeds - PYMNTS.com

May 27, 2025
pulisher
May 27, 2025

BTIG maintains Alcon stock Buy rating, $99 target - Investing.com

May 27, 2025

Alcon Inc (ALC) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_instruments_supplies BDX
$177.27
price down icon 0.23%
medical_instruments_supplies RMD
$255.88
price down icon 0.15%
medical_instruments_supplies WST
$221.22
price down icon 0.54%
medical_instruments_supplies BAX
$31.13
price down icon 0.32%
$65.30
price down icon 0.05%
大文字化:     |  ボリューム (24 時間):